Status:
COMPLETED
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
15-65 years
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is studying...
Detailed Description
OBJECTIVES: * To identify microRNAs that behave as oncogenes or as tumor suppressor genes in B-lineage acute lymphoblastic leukemia (ALL) in vitro and in vivo. * To examine if single microRNA or sign...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Samples from patients enrolled on ECOG-2993
- Samples from patients with recurrent cytogenetic abnormalities other than BCR-ABL, including MLL/AF4, E2A/PBX1, and TEL/AML1
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
January 6 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 6 2012
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT01505699
Start Date
January 6 2012
End Date
February 6 2012
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.